Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with ...

Medicare fraud costs Americans about $60 billion each year and healthcare plans are stepping in spread awareness and stop ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.

Patients with pulmonary arterial hypertension often experienced delays in obtaining a correct diagnosis. The American Lung ...

Researchers are currently enrolling participants to test the effectiveness of a rectal douche containing the antiretroviral ...

Laser therapies may help with pain after a root canal, but a review of published studies shows their effectiveness can vary significantly. Further research is needed to identify the optimal approach.

In contrast to electroconvulsive therapy, patients are not sedated during the treatments. Studies of a protocol called ...

A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are ...

The FDA assigned a Prescription Drug User Fee Act (PDUFA) date of April 2, 2025, for reproxalap for patients with dry eye ...

Because of the recent decline in the star ratings published by CMS, it is critical for Medicare Advantage plans to achieve high star ratings. Star ratings are essential to the growth, success, and ...